Oxidative Response Networks in Chagasic Cardiomyopathy

恰加斯心肌病的氧化反应网络

基本信息

  • 批准号:
    7994825
  • 负责人:
  • 金额:
    $ 36.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-01-01 至 2013-11-30
  • 项目状态:
    已结题

项目摘要

Chronic chagasic cardiomyopathy (CCM) is a major cause for heart failure related mortality and morbidity of humans. Trypanosoma cruzi is the etiological agent, however, clinical disease does not correlate with parasite presence, and host factors are likely involved in activation and/or sustenance of CCM pathogenesis. In recent studies, we have shown that chagasic animals and patients sustain mitochondrial dysfunction of respiratory chain. At functional level, mitochondrial damage resulted in a decrease in energy output and an increase in oxidative stress both of which can play a pivotal role in cardiovascular homeostasis associated with CCM. Thus, in this proposal, we plan to investigate the critical importance of mitochondrial dysfunction and oxidative stress in human Chagas disease severity. Our central hypothesis is that infection by T. cruzi elicits mt damage in cardiomyocytes that results in a continuing cycle of respiratory chain inefficiency and ROS formation. These ROS cause cellular oxidative damage, and lead to the development of progressive cardiac pathology and impaired LV function in human chagasic patients. To test this hypothesis, we will conduct a cross-sectional study with following specific aims: 1) Identify the molecular, biochemical, and functional changes in mt that cause impaired metabolic activity and constitute a risk factor in human Chagas disease, 2) Determine how ROS-induced oxidative cellular damage enhance the patients¿ risk to develop clinical symptoms of Chagas disease, and 3) Identify the molecular pathways that are affected by mt and cellular oxidative stress and contribute to myocardial structural and functional alterations during progressive CCM. Samples from cardiomyopathy patients of other etiologies and healthy subjects will be analyzed for comparison purposes. Upon completion of the proposed studies, we anticipate demonstrating the importance of oxidative stress in instigation and/or sustenance of pathological processes (mt metabolic alterations, oxidative processes, cardiac remodeling) during CCM development. The comparative analysis with cardiomyopathy patients of other etiologies would provide insight into the mechanisms of cardiomyopathy development, and identify whether inhibiting oxidative responses would be useful in preventing cardiac damage. We anticipate identifying novel targets for the development of combinatorial therapies for preserving the cardiomyocyte composition and heart function that will be useful in controlling the onset/progression of chronic cardiomyopathy. We will conduct these studies in collaboration with multiple national and international collaborators, and as a result, our collaborators at the Argentina study site will gain training in cutting edge molecular and biochemical approaches, thus, enhancing their research capabilities in cardiovascular infectious diseases.
慢性恰加斯心肌病(CCM)是心力衰竭相关死亡率和发病率的主要原因 人类的。克氏锥虫是病原,但临床疾病与 寄生虫的存在和宿主因素可能参与 CCM 发病机制的激活和/或维持。 In recent studies, we have shown that chagasic animals and patients sustain mitochondrial dysfunction of 呼吸链。 At functional level, mitochondrial damage resulted in a decrease in energy output and an 氧化应激的增加,这两者都可以在与心血管相关的稳态中发挥关键作用 CCM。 Thus, in this proposal, we plan to investigate the critical importance of mitochondrial dysfunction and 氧化应激影响人类恰加斯病的严重程度。 Our central hypothesis is that infection by T. cruzi elicits mt damage in cardiomyocytes that results in a continuing cycle of respiratory chain inefficiency and ROS 形成。这些 ROS 会引起细胞氧化损伤,并导致进行性心脏疾病的发生 人类恰加斯病患者的病理学和左心室功能受损。为了检验这个假设,我们将进行 具有以下具体目标的横断面研究: 1) 识别导致代谢活动受损的 mt 的分子、生化和功能变化 并构成人类恰加斯病的危险因素, 2) 确定ROS诱导的氧化细胞损伤如何增加患者发生临床症状的风险 恰加斯病的症状,以及 3) Identify the molecular pathways that are affected by mt and cellular oxidative stress and contribute to myocardial structural and functional alterations during progressive CCM. Samples from cardiomyopathy patients of other etiologies and healthy subjects will be analyzed for 比较目的。完成拟议的研究后,我们预计将证明其重要性 of oxidative stress in instigation and/or sustenance of pathological processes (mt metabolic alterations, CCM 发育过程中的氧化过程、心脏重塑)。与的对比分析 cardiomyopathy patients of other etiologies would provide insight into the mechanisms of cardiomyopathy development, and identify whether inhibiting oxidative responses would be useful in preventing cardiac 损害。 We anticipate identifying novel targets for the development of combinatorial therapies for preserving the cardiomyocyte composition and heart function that will be useful in controlling the onset/progression of 慢性心肌病。 We will conduct these studies in collaboration with multiple national and international collaborators, and as a result, our collaborators at the Argentina study site will gain training in cutting edge molecular and biochemical approaches, thus, enhancing their research capabilities in cardiovascular infectious diseases.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nisha Jain Garg其他文献

NADPH Oxidase: Role in Progression of Myocarditis During Trypanosoma cruzi Infection and Chagas Disease
  • DOI:
    10.1016/j.freeradbiomed.2010.10.393
  • 发表时间:
    2010-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Nisha Jain Garg;Monisha Dhiman
  • 通讯作者:
    Monisha Dhiman

Nisha Jain Garg的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nisha Jain Garg', 18)}}的其他基金

Targeting HNF4-induced thrombo-inflammation in Chagas disease
针对恰加斯病中 HNF4 诱导的血栓炎症
  • 批准号:
    10727268
  • 财政年份:
    2023
  • 资助金额:
    $ 36.68万
  • 项目类别:
Mitochondrial Biomarkers of Cardiomyopathy and Cure in Chagas Disease
心肌病的线粒体生物标志物和恰加斯病的治疗
  • 批准号:
    8666721
  • 财政年份:
    2013
  • 资助金额:
    $ 36.68万
  • 项目类别:
Mitochondrial Biomarkers of Cardiomyopathy and Cure in Chagas Disease
心肌病的线粒体生物标志物和恰加斯病的治疗
  • 批准号:
    8568036
  • 财政年份:
    2013
  • 资助金额:
    $ 36.68万
  • 项目类别:
Oxidative Response Networks in Chagasic Cardiomyopathy
恰加斯心肌病的氧化反应网络
  • 批准号:
    7567886
  • 财政年份:
    2009
  • 资助金额:
    $ 36.68万
  • 项目类别:
Oxidative Response Networks in Chagasic Cardiomyopathy
恰加斯心肌病的氧化反应网络
  • 批准号:
    8210908
  • 财政年份:
    2009
  • 资助金额:
    $ 36.68万
  • 项目类别:
Oxidative Response Networks in Chagasic Cardiomyopathy
恰加斯心肌病的氧化反应网络
  • 批准号:
    9751200
  • 财政年份:
    2009
  • 资助金额:
    $ 36.68万
  • 项目类别:
Oxidative Response Networks in Chagasic Cardiomyopathy
恰加斯心肌病的氧化反应网络
  • 批准号:
    9571194
  • 财政年份:
    2009
  • 资助金额:
    $ 36.68万
  • 项目类别:
Oxidative Response Networks in Chagasic Cardiomyopathy
恰加斯心肌病的氧化反应网络
  • 批准号:
    10219916
  • 财政年份:
    2009
  • 资助金额:
    $ 36.68万
  • 项目类别:
Oxidative Response Networks in Chagasic Cardiomyopathy
恰加斯心肌病的氧化反应网络
  • 批准号:
    7752870
  • 财政年份:
    2009
  • 资助金额:
    $ 36.68万
  • 项目类别:
Human serum carbonyl proteome in cardiovascular diseases
心血管疾病中的人血清羰基蛋白质组
  • 批准号:
    7530425
  • 财政年份:
    2008
  • 资助金额:
    $ 36.68万
  • 项目类别:

相似国自然基金

TMEM8B-a 多聚化修饰降解 ATP2A2 蛋白抑制肺癌细胞集体侵袭的分子机制及靶向抑制剂转化应用研究
  • 批准号:
    2022JJ10096
  • 批准年份:
    2022
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于单细胞测序解析miR-4632靶向ATP2A2调控NLRP3焦亡信号促进肺动脉高压血管重塑的作用机制研究
  • 批准号:
    82241015
  • 批准年份:
    2022
  • 资助金额:
    50.00 万元
  • 项目类别:
    专项项目
TMEM8B-a多聚化修饰降解ATP2A2蛋白抑制肺癌细胞集体侵袭的分子机制及相应靶向抑制剂转化应用研究
  • 批准号:
    82172879
  • 批准年份:
    2021
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
重度智力障碍并癫痫候选易感/致病基因ATP2A2、RYR1和RYR2分析验证及发病机制的研究
  • 批准号:
    81771408
  • 批准年份:
    2017
  • 资助金额:
    70.0 万元
  • 项目类别:
    面上项目

相似海外基金

A Tbx5-Atp2a2 gene regulatory network for cardiac rhythm - Resubmission 01
心律的 Tbx5-Atp2a2 基因调控网络 - 重新提交 01
  • 批准号:
    9761177
  • 财政年份:
    2019
  • 资助金额:
    $ 36.68万
  • 项目类别:
ATP2A2-Regulated Keretinocyted Ca2+ Signaling Mechanisms
ATP2A2 调节角质形成细胞 Ca2 信号传导机制
  • 批准号:
    8914890
  • 财政年份:
    2006
  • 资助金额:
    $ 36.68万
  • 项目类别:
ATP2A2-Regulated Keratinocyte Ca2+ Signaling Mechanisms
ATP2A2 调节角质形成细胞 Ca2 信号传导机制
  • 批准号:
    7139719
  • 财政年份:
    2006
  • 资助金额:
    $ 36.68万
  • 项目类别:
ATP2A2-Regulated Keratinocyte Ca2+ Signaling Mechanisms
ATP2A2 调节角质形成细胞 Ca2 信号传导机制
  • 批准号:
    7910681
  • 财政年份:
    2006
  • 资助金额:
    $ 36.68万
  • 项目类别:
ATP2A2-Regulated Keratinocyte Ca2+ Signaling Mechanisms
ATP2A2 调节角质形成细胞 Ca2 信号传导机制
  • 批准号:
    7482363
  • 财政年份:
    2006
  • 资助金额:
    $ 36.68万
  • 项目类别:
ATP2A2-Regulated Keratinocyte Ca2+ Signaling Mechanisms
ATP2A2 调节角质形成细胞 Ca2 信号传导机制
  • 批准号:
    7283820
  • 财政年份:
    2006
  • 资助金额:
    $ 36.68万
  • 项目类别:
ATP2A2-Regulated Keratinocyte Ca2+ Signaling Mechanisms
ATP2A2 调节角质形成细胞 Ca2 信号传导机制
  • 批准号:
    7669110
  • 财政年份:
    2006
  • 资助金额:
    $ 36.68万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了